54 related articles for article (PubMed ID: 36110989)
1. HMGA1 is a Prognostic Biomarker and Correlated with Glycolysis in Lung Adenocarcinoma.
Ma Y; Ma X; Du B; Li X; Li Y
J Cancer; 2024; 15(10):2913-2927. PubMed ID: 38706894
[No Abstract] [Full Text] [Related]
2. SIRT2 as a Potential Biomarker in Lung Adenocarcinoma: Implications for Immune Infiltration.
Zhang G; Lu S; Ren Z; Wei L; Chen C; Tao P; Pan X
Mol Biotechnol; 2024 Jun; ():. PubMed ID: 38902578
[TBL] [Abstract][Full Text] [Related]
3. PERP May Affect the Prognosis of Lung Adenocarcinoma by Inhibiting Apoptosis.
Liu Z; Han S; Luo Y; Zhao Z; Ni L; Chai L; Tang H
Cancer Manag Res; 2024; 16():199-214. PubMed ID: 38525370
[TBL] [Abstract][Full Text] [Related]
4. ITGB4 is a prognostic biomarker and correlated with lung adenocarcinoma brain metastasis.
Zhang J; Li L; Luo W; Ma S; Zhao Y
Clin Transl Oncol; 2024 May; ():. PubMed ID: 38776034
[TBL] [Abstract][Full Text] [Related]
5. Low Expression MCEMP1 Promoting Lung Adenocarcinoma Progression by and its Clinical Value.
Ling L; Hu T; Zhou C; Chen S; Chou L; Chen Y; Hu Z; Huang K; Chen J; Wang Y; Wang J
Curr Cancer Drug Targets; 2024 Apr; ():. PubMed ID: 38676531
[TBL] [Abstract][Full Text] [Related]
6. LncRNA-AC02278.4 Is a Novel Prognostic Biomarker That Promotes Tumor Growth and Metastasis in Lung Adenocarcinoma.
Chen X; Zhou F; Ren W; Guo J; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2022; 12():860961. PubMed ID: 35463380
[TBL] [Abstract][Full Text] [Related]
7. NEDD1 overexpression increases cell proliferation, tumor immune escape, and drug resistance in LUAD.
Zhuo T; Wu Z; Chen S; Yang C; Huang H; Gan J; Lyu J; Xiao J; Li Z; Qin S; Wu Y
J Cancer; 2024; 15(9):2460-2474. PubMed ID: 38577589
[No Abstract] [Full Text] [Related]
8. Lineage specification in glioblastoma is regulated by METTL7B.
Constantinou M; Nicholson J; Zhang X; Maniati E; Lucchini S; Rosser G; Vinel C; Wang J; Lim YM; Brandner S; Nelander S; Badodi S; Marino S
Cell Rep; 2024 Jun; 43(6):114309. PubMed ID: 38848215
[TBL] [Abstract][Full Text] [Related]
9. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia.
Fu C; Kou R; Meng J; Jiang D; Zhong R; Dong M
BMC Med Genomics; 2023 Aug; 16(1):191. PubMed ID: 37596597
[TBL] [Abstract][Full Text] [Related]
10. Methyltransferase-like proteins in cancer biology and potential therapeutic targeting.
Qi YN; Liu Z; Hong LL; Li P; Ling ZQ
J Hematol Oncol; 2023 Aug; 16(1):89. PubMed ID: 37533128
[TBL] [Abstract][Full Text] [Related]
11. Heart failure-related genes associated with oxidative stress and the immune landscape in lung cancer.
Duan R; Ye K; Li Y; Sun Y; Zhu J; Ren J
Front Immunol; 2023; 14():1167446. PubMed ID: 37275875
[TBL] [Abstract][Full Text] [Related]
12. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway.
Li M; Wu R; Zhu D; Wang L; Liu S; Wang R; Deng C; Zhang S; Chen M; Lu R; Zhu H; Mo M; Luo Z
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165929
[TBL] [Abstract][Full Text] [Related]
13. METTL7B serves as a prognostic biomarker and promotes metastasis of lung adenocarcinoma cells.
Li R; Mu C; Cao Y; Fan Y
Ann Transl Med; 2022 Aug; 10(16):895. PubMed ID: 36110989
[TBL] [Abstract][Full Text] [Related]
14. METTL7B (methyltransferase-like 7B) identification as a novel biomarker for lung adenocarcinoma.
Ali J; Liu W; Duan W; Liu C; Song J; Ali S; Li E; Wang Q
Ann Transl Med; 2020 Sep; 8(18):1130. PubMed ID: 33240979
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of hsa-miR-30b-3p Inhibits the Oncogenicity of Lung Adenocarcinoma by Targeting the
Li N; Li R; Song B; Ge H; Qu Y
J Oncol; 2022; 2022():6883140. PubMed ID: 35646115
[TBL] [Abstract][Full Text] [Related]
16.
Xu T; Xu S; Yao Y; Chen X; Zhang Q; Zhao X; Wang X; Zhu J; Liu N; Zhang J; Lin Y; Zou J
J Thorac Dis; 2022 Feb; 14(2):515-535. PubMed ID: 35280459
[TBL] [Abstract][Full Text] [Related]
17. Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma.
Song H; Liu D; Wang L; Liu K; Chen C; Wang L; Ren Y; Ju B; Zhong F; Jiang X; Wang G; Chen ZS; Zou C
Mol Cancer; 2022 Feb; 21(1):43. PubMed ID: 35144642
[TBL] [Abstract][Full Text] [Related]
18. Defining the elusive oncogenic role of the methyltransferase TMT1B.
Denford SE; Wilhelm BT
Front Oncol; 2023; 13():1211540. PubMed ID: 37456227
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
